Management of hypertrophic cardiomyopathy relies on risk stratification for sudden death using implantable cardioverter defibrillators and symptom relief with beta-blockers, verapamil, or surgery.
TEST 02 - Elsevier's Scopus, the largest abstract and citation database of peer-reviewed literature. Search and access research from the science, technology, medicine, social sciences and arts and humanities fields.
Spirito et al. (2006) conducted a review in Hypertrophic cardiomyopathy. Management of hypertrophic cardiomyopathy relies on risk stratification for sudden death using implantable cardioverter defibrillators and symptom relief with beta-blockers, verapamil, or surgery.